Discover 1,141 paid clinical trials in Waterbury, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,141
Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry
for
Stress Urinary Incontinence, Pelvic Organ Prolapse
Location: New Haven CT, Philadelphia PA, Pittsburgh PA, Durham NC
Sponsor: Ethicon, Inc.
Sex: Female
Age: 21+
Code: NCT04829175
Recruiting
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: New Haven CT, West Haven CT, Stony Brook NY, Commack NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06317649
Phase2, Recruiting
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)
for
Opioid Use Disorder
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 25 - 55
Code: NCT06160284
Phase1, Recruiting
The Recovery in Stroke Using PAP Study
for
Ischemic Stroke, Obstructive Sleep Apnea
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT04130503
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
for
Acute Myeloid Leukemia,
Location: New Haven CT, West Haven CT, Stony Brook NY, Commack NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05564390
Phase2, Recruiting
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
for
Intracranial Meningioma, Recurrent Meningioma,
Location: New Haven CT, Hartford CT, Trumbull CT, Montvale NJ,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT02523014
Phase2, Recruiting
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations